Artiva Biotherapeutics
ARTV----
Artiva Biotherapeutics (ARTV)
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Artiva Biotherapeutics Analyst Rating
View MoreForecast & Rating
Jun 11, 2026Price forecast
$35.80256.93%
Forecast & RatingStrong buy
6analysts
- Strong buy83.33%
- Buy16.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 08:23 PM
RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares
- PUBT · Jul 22 at 04:16 PM
Artiva Biotherapeutics announces 2026 annual shareholder meeting
- Tip Ranks · Jul 20 at 09:02 PM
Major Insider Move Signals Growing Confidence in Artiva Biotherapeutics
- PUBT · Jul 20 at 05:09 PM
RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics shares
- PUBT · Jul 17 at 06:30 AM
Artiva Biotherapeutics issues 288,800 RSUs to 17 new hires under inducement plan
- StockTitan · Jul 16 at 10:30 PM
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ARTV Stock News
